Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Dermatology

Journal Scan / Research · January 22, 2015

Use of Oral and Topical Beta Blockers for Infantile Hemangiomas

Pediatric Dermatology

 

Additional Info

Disclosure statements are available on the authors' profiles:

Pediatric Dermatology
Outpatient Use of Oral Propranolol and Topical Timolol for Infantile Hemangiomas: Survey Results and Comparison With Propranolol Consensus Statement Guidelines
Pediatr Dermatol 2014 Dec 29;[EPub Ahead of Print], MG Kumar, C Coughlin, SJ Bayliss

Further Reading